77 related articles for article (PubMed ID: 31768844)
1. The Antiproliferative Effect of the "Early" Protein E2 of Papillomavirus HPV16 on Testis Tumors of Mice Induced by the Injection of HeLa Cells.
Salyaev RK; Rekoslavskaya NI; Stolbikov AS
Dokl Biochem Biophys; 2019 Sep; 488(1):296-299. PubMed ID: 31768844
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
3. Methylation at 3'LCR of HPV16 can be affected by patient age and disruption of E1 or E2 genes.
Filho SMA; Bertoni N; Brant AC; Vidal JPCB; Felix SP; Cavalcanti SMB; Carestiato FN; Martins LFL; Almeida LM; Moreira MAM
Virus Res; 2017 Mar; 232():48-53. PubMed ID: 28143725
[TBL] [Abstract][Full Text] [Related]
4. HPV16 E2 variants correlated with radiotherapy treatment and biological significance in cervical cell carcinoma.
Kahla S; Hammami S; Kochbati L; Chanoufi MB; Oueslati R
Infect Genet Evol; 2018 Nov; 65():238-243. PubMed ID: 30081093
[TBL] [Abstract][Full Text] [Related]
5. The association of human papillomavirus type 16 E2 variations with cervical cancer in a Han Chinese population.
Dai S; Yao Y; Yan Z; Zhou Z; Shi L; Wang X; Sun L; Zhang R; Yao Y
Infect Genet Evol; 2018 Oct; 64():241-248. PubMed ID: 30008422
[TBL] [Abstract][Full Text] [Related]
6. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
7. TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin.
Donaldson MM; Boner W; Morgan IM
J Virol; 2007 Apr; 81(8):4338-42. PubMed ID: 17287259
[TBL] [Abstract][Full Text] [Related]
8. The Deacetylase SIRT1 Regulates the Replication Properties of Human Papillomavirus 16 E1 and E2.
Das D; Smith N; Wang X; Morgan IM
J Virol; 2017 May; 91(10):. PubMed ID: 28275188
[TBL] [Abstract][Full Text] [Related]
9. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
10. The human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation.
Siddiqa A; Léon KC; James CD; Bhatti MF; Roberts S; Parish JL
J Gen Virol; 2015 Aug; 96(8):2274-2285. PubMed ID: 25911730
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the nuclear localization signal of high risk HPV16 E2 protein.
Klucevsek K; Wertz M; Lucchi J; Leszczynski A; Moroianu J
Virology; 2007 Mar; 360(1):191-8. PubMed ID: 17097712
[TBL] [Abstract][Full Text] [Related]
12. The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins.
Stubenrauch F; Straub E; Fertey J; Iftner T
Int J Cancer; 2007 Nov; 121(10):2284-92. PubMed ID: 17583574
[TBL] [Abstract][Full Text] [Related]
13. The Induction of the Synthesis of Interferon, CD4 and CD8 T Lymphocytes in Blood and Spleen of Mice after Oral Vaccination with the "Early" Protein HPV16 E2.
Salyaev RK; Rekoslavskaya NI; Stolbikov AS
Dokl Biochem Biophys; 2019 Sep; 488(1):316-319. PubMed ID: 31768850
[TBL] [Abstract][Full Text] [Related]
14. Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.
Reuschenbach M; Huebbers CU; Prigge ES; Bermejo JL; Kalteis MS; Preuss SF; Seuthe IM; Kolligs J; Speel EJ; Olthof N; Kremer B; Wagner S; Klussmann JP; Vinokurova S; von Knebel Doeberitz M
Cancer; 2015 Jun; 121(12):1966-76. PubMed ID: 25731880
[TBL] [Abstract][Full Text] [Related]
15. HPV16/18 E5, a promising candidate for cervical cancer vaccines, affects SCPs, cell proliferation and cell cycle, and forms a potential network with E6 and E7.
Liao S; Deng D; Hu X; Wang W; Li L; Li W; Zhou J; Xu G; Meng L; Wang S; Ma D
Int J Mol Med; 2013 Jan; 31(1):120-8. PubMed ID: 23128250
[TBL] [Abstract][Full Text] [Related]
16. Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma.
Kahla S; Kochbati L; Maalej M; Oueslati R
Asian Pac J Cancer Prev; 2014; 15(6):2869-73. PubMed ID: 24761916
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms and functional analysis of the intact human papillomavirus16 e2 gene.
Ekalaksananan T; Jungpol W; Prasitthimay C; Wongjampa W; Kongyingyoes B; Pientong C
Asian Pac J Cancer Prev; 2014; 15(23):10255-62. PubMed ID: 25556457
[TBL] [Abstract][Full Text] [Related]
18. Calcein represses human papillomavirus 16 E1-E2 mediated DNA replication via blocking their binding to the viral origin of replication.
Das D; Smith NW; Wang X; Richardson SL; Hartman MCT; Morgan IM
Virology; 2017 Aug; 508():180-187. PubMed ID: 28570919
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic adenovirus armed with human papillomavirus E2 gene in combination with radiation demonstrates synergistic enhancements of antitumor efficacy.
Wang W; Xia X; Wang S; Sima N; Li Y; Han Z; Gao Q; Luo A; Li K; Meng L; Zhou J; Wang C; Shen K; Ma D
Cancer Gene Ther; 2011 Nov; 18(11):825-36. PubMed ID: 21852812
[TBL] [Abstract][Full Text] [Related]
20. HPV16-E2 protein modifies self-renewal and differentiation rate in progenitor cells of human immortalized keratinocytes.
Domínguez-Catzín V; Reveles-Espinoza AM; Sánchez-Ramos J; Cruz-Cadena R; Lemus-Hernández D; Garrido E
Virol J; 2017 Apr; 14(1):65. PubMed ID: 28372578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
